Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.

Exclusion Criteria

• •Patients with abnormal sensory findings on examination, or any known neurological disease that may affect skin sensation (peripheral neuropathy, multiple sclerosis, stroke, etc).
• •Patients who suffer from headache (of any type) 15 or more days per month
• •Patients who are cognitively impaired, as determined by investigator
• •Patients with significant psychiatric disorder that may affect their understanding of the study protocol and/or their cooperation with the investigators.
• •Patients who had taken any acute pain medication (e.g. triptans, ergots, NSAIDs, opioids, butalbital, acetaminophen) for any indication within 12 hours prior to allodynia testing.
• •Patients with skin diseases that may cause abnormal skin sensation.
• •Patients who had been treated with a nerve block in the 4 week period prior to allodynia testing Patients who had been treated with Botulinum neurotoxin within the 4 month period prior to allodynia testing